PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28133913-5	2017	siRNA manipulation of ZEB1 and ZEB2 in PC-3 and DU145 docetaxel-resistant sublines identified ZEB1, through its transcriptional repression of E-cadherin, to be a driver of both EMT and docetaxel resistance.	Docetaxel	54-63	cadherin 1	Homo sapiens	142-152	
31452801-12	2019	Reverse transcription-quantitative PCR analysis performed on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines demonstrated that certain hub genes, including CDK1, 2"-5"-oligoadenylate synthetase 3, CXCL8 and CDH1, were highly expressed in the docetaxel-resistant cell lines, which confirmed the bioinformatics results.	Docetaxel	61-70	cadherin 1	Homo sapiens	230-234	
31452801-12	2019	Reverse transcription-quantitative PCR analysis performed on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines demonstrated that certain hub genes, including CDK1, 2"-5"-oligoadenylate synthetase 3, CXCL8 and CDH1, were highly expressed in the docetaxel-resistant cell lines, which confirmed the bioinformatics results.	Docetaxel	85-94	cadherin 1	Homo sapiens	230-234	
31452801-12	2019	Reverse transcription-quantitative PCR analysis performed on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines demonstrated that certain hub genes, including CDK1, 2"-5"-oligoadenylate synthetase 3, CXCL8 and CDH1, were highly expressed in the docetaxel-resistant cell lines, which confirmed the bioinformatics results.	Docetaxel	85-94	cadherin 1	Homo sapiens	230-234	
28133913-7	2017	This study presents evidence for a role of ZEB1, through its transcriptional repression of E-cadherin to be a driver of both EMT and docetaxel resistance in docetaxel-resistant prostate cancer.	Docetaxel	133-142	cadherin 1	Homo sapiens	91-101	
28133913-7	2017	This study presents evidence for a role of ZEB1, through its transcriptional repression of E-cadherin to be a driver of both EMT and docetaxel resistance in docetaxel-resistant prostate cancer.	Docetaxel	157-166	cadherin 1	Homo sapiens	91-101	
25279705-10	2014	Taken together, the HDAC1/miR-200b/Suz-12-E-cadherin signaling might account for maintenance of CSCs and formation of chemoresistant phenotype in docetaxel-resistant LAD cells.	Docetaxel	146-155	cadherin 1	Homo sapiens	42-52	
22027694-11	2012	Analysis in patients showed a noteworthy downexpression of CDH1 and IFIH1, among others, in docetaxel-resistant tumors.	Docetaxel	92-101	cadherin 1	Homo sapiens	59-63	
23041061-4	2012	In this study, we report that docetaxel-resistant cells underwent an epithelial-to-mesenchymal transition during the selection process, leading to diminished E-cadherin levels and up-regulation of mesenchymal markers.	Docetaxel	30-39	cadherin 1	Homo sapiens	158-168	
34281228-10	2021	Combined treatment led to high-efficacy effects on MCF-7 cells, which were associated to the up-regulation of CDKN1A, BAX, caspase 9 and E-cadherin mRNA under combined treatment compared to single DOCE treatment.	Docetaxel	197-201	cadherin 1	Homo sapiens	137-147	
9066624-0	1997	Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro.	Docetaxel	0-9	cadherin 1	Homo sapiens	37-47	
9066624-2	1997	Docetaxel was shown to increase the expression of E-cadherin and CEA in the low concentration range of 3 x 10(-10) M - 3 x 10(-9) M for HT-29 cells and 0.6 - 3 x 10(-9) M for SW620 cells.	Docetaxel	0-9	cadherin 1	Homo sapiens	50-60	
9066624-3	1997	Docetaxel strongly increased CEA (270%) and E-cadherin (160%) expression in HT-29 cells, compared with both marker expression in SW620 cells (60%).	Docetaxel	0-9	cadherin 1	Homo sapiens	44-54	
9066624-4	1997	E-cadherin and CEA expression were found to be inversely correlated to the antiproliferating potential of docetaxel, which inhibits the cell proliferation of HT-29 cells at an IC50 of 6 x 10(-10) M and of SW620 cells at 8 x 10(-10) M. The data suggest, that in addition to its antiproliferative activity docetaxel also exhibits a strong differentiation inducing capacity at concentrations < 10(-9) M in vitro.	Docetaxel	106-115	cadherin 1	Homo sapiens	0-10	
9066624-4	1997	E-cadherin and CEA expression were found to be inversely correlated to the antiproliferating potential of docetaxel, which inhibits the cell proliferation of HT-29 cells at an IC50 of 6 x 10(-10) M and of SW620 cells at 8 x 10(-10) M. The data suggest, that in addition to its antiproliferative activity docetaxel also exhibits a strong differentiation inducing capacity at concentrations < 10(-9) M in vitro.	Docetaxel	304-313	cadherin 1	Homo sapiens	0-10